Saad F - Search Results

1

Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial.

Saad F, Fizazi K, Jinga V, Efstathiou E, Fong PC, Hart LL, Jones R, McDermott R, Wirth M, Suzuki K, MacLean DB, Wang L, Akaza H, Nelson J, Scher HI, Dreicer R, Webb IJ, de Wit R; ELM-PC 4 investigators. Saad F, et al. Lancet Oncol. 2015 Mar;16(3):338-48. doi: 10.1016/S1470-2045(15)70027-6. Epub 2015 Feb 18. Lancet Oncol. 2015. PMID: 25701170 Clinical Trial.

2

A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma.

Saad F, Gleason DM, Murray R, Tchekmedyian S, Venner P, Lacombe L, Chin JL, Vinholes JJ, Goas JA, Chen B; Zoledronic Acid Prostate Cancer Study Group. Saad F, et al. J Natl Cancer Inst. 2002 Oct 2;94(19):1458-68. doi: 10.1093/jnci/94.19.1458. J Natl Cancer Inst. 2002. PMID: 12359855 Clinical Trial.

3

The role of bisphosphonates in the management of prostate cancer.

Saad F. Saad F. Curr Oncol Rep. 2006 May;8(3):221-7. doi: 10.1007/s11912-006-0023-7. Curr Oncol Rep. 2006. PMID: 16618387 Review.

4

A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer.

Carducci MA, Saad F, Abrahamsson PA, Dearnaley DP, Schulman CC, North SA, Sleep DJ, Isaacson JD, Nelson JB; Atrasentan Phase III Study Group Institutions. Carducci MA, et al. Among authors: saad f. Cancer. 2007 Nov 1;110(9):1959-66. doi: 10.1002/cncr.22996. Cancer. 2007. PMID: 17886253 Free article. Clinical Trial.

5

The Canadian Uro-Oncology Group multicentre phase II study of docetaxel administered every 3 weeks with prednisone in men with metastatic hormone-refractory prostate cancer progressing after mitoxantrone/prednisone.

Saad F, Ruether D, Ernst S, North S, Cheng T, Perrotte P, Karakiewicz P, Winquist E; Canadian Uro-Oncology Group. Saad F, et al. BJU Int. 2008 Aug 5;102(5):551-5. doi: 10.1111/j.1464-410X.2008.07733.x. Epub 2008 May 28. BJU Int. 2008. PMID: 18510661 Clinical Trial.

6

Preservation of bone health in prostate cancer.

Lattouf JB, Saad F. Lattouf JB, et al. Among authors: saad f. Curr Opin Support Palliat Care. 2007 Oct;1(3):192-7. doi: 10.1097/SPC.0b013e3282f0c74f. Curr Opin Support Palliat Care. 2007. PMID: 18685362 Review.

7

Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone-refractory prostate cancer.

Nelson JB, Love W, Chin JL, Saad F, Schulman CC, Sleep DJ, Qian J, Steinberg J, Carducci M; Atrasentan Phase 3 Study Group. Nelson JB, et al. Among authors: saad f. Cancer. 2008 Nov 1;113(9):2478-87. doi: 10.1002/cncr.23864. Cancer. 2008. PMID: 18785254 Free PMC article. Clinical Trial.

8

Maintaining bone health in prostate cancer throughout the disease continuum.

Saad F, Eastham J. Saad F, et al. Semin Oncol. 2010 Jun;37 Suppl 1:S30-7. doi: 10.1053/j.seminoncol.2010.06.007. Semin Oncol. 2010. PMID: 20682370 Review.

9

Randomized phase II study of docetaxel and prednisone with or without OGX-011 in patients with metastatic castration-resistant prostate cancer.

Chi KN, Hotte SJ, Yu EY, Tu D, Eigl BJ, Tannock I, Saad F, North S, Powers J, Gleave ME, Eisenhauer EA. Chi KN, et al. Among authors: saad f. J Clin Oncol. 2010 Sep 20;28(27):4247-54. doi: 10.1200/JCO.2009.26.8771. Epub 2010 Aug 23. J Clin Oncol. 2010. PMID: 20733135 Clinical Trial.

10

Management of castration-resistant prostate cancer: bisphosphonates and emerging therapies.

Saad F, Colombel M. Saad F, et al. Expert Rev Anticancer Ther. 2010 Dec;10(12):1991-2002. doi: 10.1586/era.10.191. Expert Rev Anticancer Ther. 2010. PMID: 21110764 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,349 results

Search Page